UCB PHARMA GMBH PATENTS FACING OPPOSITIONS
Top patents of UCB PHARMA GMBH facing oppositions at the European Patent Office (EPO)
Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
EP2645997B1 |
10 Aug, 2022
|
Once Daily Formulation Of Lacosamide
|
Dec, 2031
|
1
| |
EP2992891B1 |
05 Aug, 2020
|
Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect
|
Jun, 2027
|
1
| |
EP2037965B1 |
30 Aug, 2017
|
Pharmaceutical Composition With Synergistic Anticonvulsant Effect
|
Jun, 2027
|
1
| |